Droplet / Contact Precautions
NP swab not routinely recommended but may be useful in selected circumstances (e.g. cohorting, excluding treatable viruses such as influenza)
Recommend ID consult if severe disease in immunocompromised patients, or considering antiviral therapy
Respiratory Syncitial Virus
Empiric antiviral therapy generally not recommended
Inhaled ribavirin may be used in selected cases (i.e. immunocompromised patient with severe disease); requires ID consult
RSV Prophylaxis for publicly-funded Palivizumab requires enrollment into the RSV Program.
More information can be found here
Contact the SickKids RSV Program at [email protected] for more information.